Shape-sensing robotic-assisted bronchoscopy in the diagnosis of pulmonary parenchymal lesions
O Kalchiem-Dekel, JG Connolly, IH Lin, BC Husta… - Chest, 2022 - Elsevier
Background The landscape of guided bronchoscopy for the sampling of pulmonary
parenchymal lesions is evolving rapidly. Shape-sensing robotic-assisted bronchoscopy …
parenchymal lesions is evolving rapidly. Shape-sensing robotic-assisted bronchoscopy …
Shape-sensing robotic-assisted bronchoscopy with concurrent use of radial endobronchial ultrasound and cone beam computed tomography in the evaluation of …
K Styrvoky, A Schwalk, D Pham, HT Chiu… - Lung, 2022 - Springer
Purpose Lung nodules are a common radiographic finding. Non-surgical biopsy is
recommended in patients with moderate or high pretest probability for malignancy. Shape …
recommended in patients with moderate or high pretest probability for malignancy. Shape …
Preoperative staging of the mediastinum is an essential and multidisciplinary task
J Sanz‐Santos, S Call - Respirology, 2020 - Wiley Online Library
Mediastinal staging is a crucial step in the management of patients with NSCLC. With the
recent development of novel techniques, mediastinal staging has evolved from an activity of …
recent development of novel techniques, mediastinal staging has evolved from an activity of …
Segmentectomy for patients with early-stage pure-solid non-small cell lung cancer
A Kamigaichi, A Hamada, Y Tsutani - Frontiers in Oncology, 2023 - frontiersin.org
For decades, lobectomy has been the recommended surgical procedure for non-small cell
lung cancer (NSCLC), including for small-sized lesions. However, two recent pivotal clinical …
lung cancer (NSCLC), including for small-sized lesions. However, two recent pivotal clinical …
Tumour location predicts occult N1 nodal metastasis in clinical stage I non-small-cell lung cancer
N Kawamoto, Y Tsutani, A Kamigaichi… - European Journal of …, 2023 - academic.oup.com
OBJECTIVES Pathological lymph node metastases are often observed in patients with
clinical N0 lung cancer. Identifying preoperative predictors of occult hilar nodal metastasis …
clinical N0 lung cancer. Identifying preoperative predictors of occult hilar nodal metastasis …
Central tumor location at chest CT is an adverse prognostic factor for disease-free survival of node-negative early-stage lung adenocarcinomas
Background The prognostic value of primary tumor location in the central lung is unclear
because of heterogeneity in definitions of central lung cancer (CLC). Purpose To (a) validate …
because of heterogeneity in definitions of central lung cancer (CLC). Purpose To (a) validate …
Segmentectomy for cancer control in radiologically pure-solid clinical stage IA3 lung cancer
A Kamigaichi, T Mimae, N Tsubokawa… - Interdisciplinary …, 2023 - academic.oup.com
OBJECTIVES This study aimed to compare cancer control after segmentectomy and
lobectomy in patients with radiologically pure-solid clinical stage IA3 non-small-cell lung …
lobectomy in patients with radiologically pure-solid clinical stage IA3 non-small-cell lung …
Predicting lymph node metastasis in non-small cell lung cancer: prospective external and temporal validation of the HAL and HOMER models
Background Two models, the Help with the Assessment of Adenopathy in Lung cancer
(HAL) and Help with Oncologic Mediastinal Evaluation for Radiation (HOMER), were …
(HAL) and Help with Oncologic Mediastinal Evaluation for Radiation (HOMER), were …
[HTML][HTML] Partitioning the lung field based on the depth ratio in three-dimensional space
J Huang, C Bian, W Zhang, G Mu, Z Chen… - Translational Lung …, 2022 - ncbi.nlm.nih.gov
Background To explore the feasibility of the depth ratio method partitioning the lung
parenchyma and the depth distribution of lung nodules in pulmonary segmentectomy …
parenchyma and the depth distribution of lung nodules in pulmonary segmentectomy …
A prediction model to help with oncologic mediastinal evaluation for radiation: HOMER
G Martinez-Zayas, FA Almeida, MJ Simoff… - American journal of …, 2020 - atsjournals.org
Rationale: When stereotactic ablative radiotherapy is an option for patients with non–small
cell lung cancer (NSCLC), distinguishing between N0, N1, and N2 or N3 (N2| 3) disease is …
cell lung cancer (NSCLC), distinguishing between N0, N1, and N2 or N3 (N2| 3) disease is …